Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

137 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The rapid development of fluoroquinolone resistance in M. tuberculosis.
Ginsburg AS, Woolwine SC, Hooper N, Benjamin WH Jr, Bishai WR, Dorman SE, Sterling TR. Ginsburg AS, et al. Among authors: dorman se. N Engl J Med. 2003 Nov 13;349(20):1977-8. doi: 10.1056/NEJM200311133492023. N Engl J Med. 2003. PMID: 14614180 No abstract available.
Fluoroquinolone resistance in patients with newly diagnosed tuberculosis.
Ginsburg AS, Hooper N, Parrish N, Dooley KE, Dorman SE, Booth J, Diener-West M, Merz WG, Bishai WR, Sterling TR. Ginsburg AS, et al. Among authors: dorman se. Clin Infect Dis. 2003 Dec 1;37(11):1448-52. doi: 10.1086/379328. Epub 2003 Nov 4. Clin Infect Dis. 2003. PMID: 14614666
Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
Xie YL, Chakravorty S, Armstrong DT, Hall SL, Via LE, Song T, Yuan X, Mo X, Zhu H, Xu P, Gao Q, Lee M, Lee J, Smith LE, Chen RY, Joh JS, Cho Y, Liu X, Ruan X, Liang L, Dharan N, Cho SN, Barry CE 3rd, Ellner JJ, Dorman SE, Alland D. Xie YL, et al. Among authors: dorman se. N Engl J Med. 2017 Sep 14;377(11):1043-1054. doi: 10.1056/NEJMoa1614915. N Engl J Med. 2017. PMID: 28902596 Free PMC article.
Molecular Drug-Susceptibility Test for Tuberculosis.
Chakravorty S, Xie YL, Dorman SE. Chakravorty S, et al. Among authors: dorman se. N Engl J Med. 2017 Dec 14;377(24):2404. doi: 10.1056/NEJMc1714218. N Engl J Med. 2017. PMID: 29236631 No abstract available.
Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials.
Savic RM, Weiner M, MacKenzie WR, Engle M, Whitworth WC, Johnson JL, Nsubuga P, Nahid P, Nguyen NV, Peloquin CA, Dooley KE, Dorman SE; Tuberculosis Trials Consortium of the Centers for Disease Control and Prevention. Savic RM, et al. Among authors: dorman se. Clin Pharmacol Ther. 2017 Aug;102(2):321-331. doi: 10.1002/cpt.634. Epub 2017 Mar 2. Clin Pharmacol Ther. 2017. PMID: 28124478 Free PMC article. Clinical Trial.
137 results